Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411578 · ClinicalTrials.gov registry record · Phase 2
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
A Phase 2 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT02411578: Completed Phase 2 study, sponsored by Jaeb Center for Health Research.
NCT02411578 is a Phase 2 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 26 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411578, a Phase 2 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a small dose of glucagon (mini-dose glucagon) is effective for the treatment of non-severe hypoglycemia in adults with type 1 diabetes (T1D).
Interventions
- DRUG G-Pen Mini™ (glucagon injection)
- OTHER Glucose Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
What the finished NCT02411578 record still lists
NCT02411578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which G-Pen Mini™ (glucagon injection) is the first listed.
NCT02411578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02411578 about?
NCT02411578 is a clinical study titled "Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia". The purpose of this study is to determine if a small dose of glucagon (mini-dose glucagon) is effective for the treatment of non-severe hypoglycemia in adults with type 1 diabetes (T1D).
What is the current status of trial NCT02411578?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2015-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02411578?
The interventions under investigation include: G-Pen Mini™ (glucagon injection) (DRUG), Glucose Tablets (OTHER).
Who is sponsoring clinical trial NCT02411578?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02411578's enrollment target sits among peer trials
26 1708th of 2000 higher than 282 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia